TUMOUR STEM CELLS, key cells within a neoplasm, possess the potential for repeated cycles of proliferation and serve as the seeds of metastasis. They may give rise to secondary tumour colonies at distant sites in the body and this clonogenic property has been used as the basis for in vitro assays to study the biological properties of these cells.
The value of clonogenic assays of human haemopoietic malignancies and solid tumours is now well established (Metcalf, 1977; Hamburger & Salmon, 1977a) . However, although much is known about the proliferation and kinetics of haemopoietic and tumour stem cells, information on the cytogenetics of clonogenic tumour cells remains extremely limited (Moore & Metcalf, 1973; Najfeld et al., 1978) . Cytogenetic studies of human tumour cells cloned in soft agar have been made only on tumours of haemopoietic origin. Current techniques involve hand-picking of individual colonies followed by manual dispersal before harvest of cells for cytological assessment (Moore & Metcalf, 1973) . Studies of human solid tumours using direct or short-term culture methods have also been beset with technical difficulties arising from inherently low mitotic indices and morphologically sub-optimal mitotic figures.
Our laboratory recently developed a simple soft-agar colony assay for human tumour stem cells, which can be used with established techniques for stem cell studies to analyse fresh biopsy samples from a variety of human tumours (Hamburger & Salmon, 1977a,b; Hamburger et al., 1978; Jones et al., 1979) . We report here the development and application of a simple approach for studying the cytogenetics of human tumour colonies grown in soft agar.
METHODS
Culture preparation.-Cells from human solid tumours or malignant ascites were cultured by the human tumour stem-cell assay described by Hamburger & Salmon (1977a) . Briefly, 1 ml underlayers containing the appropriate admixture of nutrient medium (with or without conditioned medium) and growth factors in 0.5%0 agar are placed into 35mm plastic Petri dishes. A single-cell suspension is prepared by mincing and teasing the freshly biopsied tumour in culture medium, followed by passage of cells and aggregates through a series of stainless-steel screens, filtration through sterile gauze, and then through needles of decreasing gauge. The resulting single cells (2-5 x 105 total) are then suspended in 1 ml of 0.3% molten agar containing enriched medium plus 15% horse serum. This is then plated over a lml 0.5% agar underlayer. Cultures are then incubated at 37°C with 7.5% CO2 in air for periods of up to 21 days. Morphology of developing colonies was observed serially with inverted phase microscopy as well as on stained samples of intact, wet, or air-dried colony-containing plating layers (Salmon & Liu, 1979; Salmon & Buick, 1979) .
Harvesting for cytogenetic analysis. (Sun et al., 1973 ) C-banding (Miller et al., 1976) or N-banding (Goodpasture & Bloom, 1975 ) is then applied to the slide. Vestiges of the agar plating layer do not appear to interfere with the various chromosome-banding techniques.
The number of mitoses found in "background" cells vs those found in the clusters was analysed by examining undisturbed plating layers with a modification of the permanent slide technique described by Salmon & Buick (1979) . Briefly, cultures are first exposed to colchicine in a manner similar to that previously described. Then, the entire intact plating layer is removed from the feeder layer and placed into a disposable plastic weighing tray. The overlying culture medium is then gently decanted with a Pasteur pipette and 24 ml of 0-075M KCI prewarmed to 37°C is added to the tray. After a 25min incubation at 37°C the hypotonic is gently removed and 10-15 ml of fresh cold fixative is added to the tray. Ten min later the supernatant is removed and the plating layer is washed twice more with fixative. The entire plating layer is then carefully poured on to a microscope slide, allowed to dry in the air, and stained with 3% Giemsa (Gurr's R-66) for 2-3 min. Although this procedure does allow identification and localization of mitoses, it is not preferred because of difficulty in obtaining satisfactory chromosome spreading and banding.
To compare the mitotic index from our short-term agar cultures with that obtained by previously described techniques, chromosome harvesting of fresh tumour biopsy samples was simultaneously performed by the "direct" harvesting technique of Shiloh & Cohen (1978) and the "liquid culture method" of Kakati et al. (1975) .
Cell counts for mitotic index.-Total cell counts per slide were obtained by using a Bausch and Lomb Omnicon Alpha 500 image analyser coupled to a microscope with an automated stage and a Hewlett Packard 9815A programmable calculator. A comparison of eye and Omnicon cell counts on microscope slides has shown them to be equally accurate (r=0-93). After determining the total cell number, the same slide is then reviewed in its entirety with conventional microscopy for observable mitoses to obtain the mitotic index. This is expressed as the total number of mitotic figures counted over the total number of cells counted.
We have used the soft-agar colony assay to study tumour colony cells in a wide variety of human cancers (Table I) . In cultures from over 500 biopsy samples, tuimour colony formation has been obtained in 5000 of all tumours. Evidence for neoplastic origin of these colonies is obtained with morphological, biomarker (e.g. immunofluorescence for carcinoembryonic antigen or myeloma proteins) and cytogenetic techniques (Table I) Normal stromal cells (e.g. fibroblasts) do not proliferate in this system; thus, available mitoses from clusters and colonies are derived from the neoplastic progenitor population. Whilst lymphoid progenitors can also be grown in soft agar, they require specific stimulators of growth other than those used by us (Metcalf, 1977) . Loose granulocytic colonies occasionally appear in these cultures. However, culture conditions are not optimal for normal myeloid growth. Evidence of the selective growth of tumour cells over normal cells in our assay system is the observation that normal diploid mitoses have not been seen in any of the 37 tumour samples studied to date.
An important feature of this procedure is the ability to isolate intact colonies and clusters in situ, omitting the tedious and selective picking of individual colonies. This allows a unique and perhaps significant visualization of colony morphology, as well as assessment of the location and number of mitotic figures within generating tumour colonies (Fig. 1) .
Comparison of our method with direct (non-clonogenic) methods (Shiloh & Cohen, 1978; Kakati et al., 1975) del(1)(pter-+q25:), del(2)(pter-*q23:), del(6)(pter-+qI5:), + 4 unidentified markers.
(e.g. MI = 1 %) this occurrence is extremely rare (Kakati & Sandberg, 1978 Fig. 2 . Tumour cells were procured from patient E.V., a 47-year-old woman in whom the diagnosis of ovarian adenocarcinoma had just been established and had not received treatment with chemotherapy or radiotherapy. Samples from the patient's primary solid tumour and a malignant ascites were obtained simultaneously, and cultured separately with the stem-cell assay. Giemsa analysis revealed a modal count of 38 in both direct harvest and colony samples, with Gbanding revealing a wealth of karyotypic variability. The most common karyotypic aberrations within the multiple stem lines present in this tumour were: 38, -X, -17, -22, del(1)(pter-*q25:), del(2)(pter-+q23:), del(6)(pter--qI5:), + 1-4 unidentified marker chromosomes (Fig. 3) . The observation in this tumour of at least 4 major karyotypically unique progenitor-cell populations is consistent with the suggestion that our assay system captures a representative sample of the clonogenic fraction within tumour samples. The structural and numerical intra-tumour chromosome variation between clonogenic populations suggests that substantial karyotypic "evolution" (progressive clonal heterogeneity) (Nowell, 1977) has already occurred in the stem-cell pool of the tumour from this untreated patient. The ability to perform chromosome-banding analysis by G-banding (Fig. 2a) to demonstrate constitutive heterochromatin by C-banding (Fig. 2b ) and selectively to silver-stain transcriptionally active cistrons for 18S and 28S ribosomal RNA by N-banding (Fig. 2c) was extremely useful in characterizing the complexly rearranged tumour-cell chromosomes in this cancer. Chromosome-banding of direct samples from this patient, although similar in modal number, provided far less information, owing to an extremely low mitotic index and morphologically suboptimal chromosomes. Interestingly, cytogenetic comparisons between the colonyforming tumour cells in both the patient's ascites and solid-tumour biopsy sample revealed a similar modal chromosome number, though a higher percentage of polyploidy was found in tumour cells from the primary site.
In addition to the marked structural chromosomal variation between this patient's tumour cells, 10% of all mitoses displayed dozens of double minute bodies (dms) (Fig. 2d) . The finding of dms in tumour cells from cluster and colony samples from this patient is strong support for the neoplastic origin of these cells (Barker & Hsu, 1979) . The occurrence of dms and acquired drug resistance have recently been associated with specific gene amplification in established animal tumour lines (Alt et al., 1978) . Cytogenetic analysis of spontaneous human tumours may display similar or additional changes in relation to resistance to methotrexate or other anticancer drugs. Cytogenetic comparisons between the clonogenic fractions before and after chemotherapy in our system may facilitate identification of unique progenitor cells resistant to specific anticancer drugs.
The procurement of chromosomes from human solid tumours by direct harvesting techniques has normally failed to provide mitotic figures morphologically suitable for Giemsa-banding. The effects of this restriction on human solid-tumour karyology is profound. Although epithelial cancers are the most common of human tumours, they have rarely been analysed with chromosome-binding techniques. Recent reviews have shown that less than 5%0 of all banded chromosomal analyses of human tumours published to date have involved carcinomas (Mitelman & Levan, 1978) . With increasing clinical application of cytogenetics to human malignancies (Golomb et al., 1978; Trent & Davis, 1979) detailed studies using chromosome-banding of human epithelial cancers is needed. Methodological improvement in the cytogenetic analysis of solid tumours and their ascites has long been sought. Use of our method should greatly facilitate detailed karyotypic assessment of a variety of human tumours and may provide important new basic and clinical observations relevant to cancer.
